Roche’s Evrysdi tablet receives US FDA approval for the treatment of spinal muscular atrophy: Basel Friday, February 14, 2025, 13:00 Hrs [IST] Roche, announced that the US Food ...

Roche's sale of InterMune and Esbriet in the US comes as Boehringer revealed its own follow-up play in the IPF, category, ...

Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...

While Roche’s Gazyva has been on the market for a dozen years and has won four approvals from the FDA, it is making a late ...

"The Evrysdi tablet combines established efficacy with convenience, providing an additional flexible option for SMA management." The approval of the Evrysdi tablet was based on the results of a ...

Officials put $1.5 million in federal pandemic recovery funds toward a machine that will be used to rebuild sand dunes wiped ...

Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...

A report on the company at the end of last year by rating agency Fitch noted that in 2021 Roche was marketing 15 drugs with $1 billion-plus sales, up from nine in 2017. With an additional 15 ...

Tweedy Browne’s 13F portfolio value decreased from $2.10B to $1.48B. Click here to read more about the trades and holdings of ...

Nestle's slumping share price is rattling shareholders and pension funds that have invested in the food giant, piling ...

Navigator Medicines, Inc., a clinical-stage biotech company leading the advancement of biologics for targeted immune ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...